Home » Topics » Regulatory

Regulatory
RSS

IVIg for acute cardiomyopathy

June 9, 1997

Generic aciclovir approved by FDA

June 9, 1997

Aciclovir demonstrates antiasthmatic activity in animal model

June 9, 1997

First approval for new MRI contrast agent from Nycomed

June 6, 1997

FDA approves generic version of Diamox

June 6, 1997

Oculex and Storz sign marketing agreement for ocular product

June 5, 1997

Didronel PMO approved for prevention of osteoporosis in U.K.

June 5, 1997

New i.v. formulation of amiodarone better tolerated in patients

June 2, 1997

Wyeth-Ayerst's Normiflo approved for prevention of deep vein thrombosis

June 2, 1997

DuPont Merck receives FDA approval for nuclear imaging breast cancer test

May 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.